JPMA Will Announce Response to Violation of PAL by Mitsubishi Tanabe in Near Future: Director General Goto

Speaking with reporters following a meeting of the Japan Pharmaceutical Manufacturers Association’s (JPMA) board of directors on October 17 about the administrative actions recently taken against Mitsubishi Tanabe Pharma Corporation (MTPC) and its subsidiary Bipha Corporation, JPMA Director General Tadaharu...read more